Skip to content
← Full study record

NCT03030261 · MORE INFO

Limitations, agreements, and source contact

Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma · Source last updated 2026-01-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rvij@wustl.edu
organization
Washington University School of Medicine
phone
314-454-8323
title
Ravi Vij, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rvij@wustl.edu
organization
Washington University School of Medicine
phone
314-454-8323
title
Ravi Vij, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice